JenniferMaloneyMD(She/Her)

Pediatrics • Sleepy Hollow, NY

Pediatric Allergy

Vice President of Clinical Sciences, Inflammation and Immunology, Clinical Lead of Dupilumab and Allergy Portfolio Regeneron

Join to view full profile

Dr. Maloney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maloney's full profile

Already have an account?

Office
777 Old Saw Mill River road
Sleepy Hollow, NY 10591

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 2004 - 2006
Stony Brook Medicine/University HospitalResidency, Pediatrics, 2000 - 2004
Stony Brook University Health Sciences Center School of MedicineClass of 2000

Certifications & Licensure

NY State Medical License 2004 - 2025
American Board of Allergy and Immunology Allergy & Immunology

Publications & Presentations

PubMed

29 citations
The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
Hendrik Nolte, Jennifer M. Maloney
Allergology International. 2018-05-16
22 citations
Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review.
Peter S. Creticos, David I. Bernstein, Thomas B. Casale, Richard F. Lockey, Jennifer Maloney
The Journal of Allergy and Clinical Immunology. in Practice. 2016-11-01
28 citations
Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.
Jennifer Maloney, Gary D. Berman, Remi Gagnon, David I. Bernstein, Harold S. Nelson
The Journal of Allergy and Clinical Immunology. in Practice. 2016-03-01

Press Mentions

AAAAI: Novel Therapy Tackles Cat AllergyMarch 2nd, 2021
FARE Retreat: Experts Explore Food Allergy Treatment, TestingSeptember 26th, 2020